Minerva Biotechnologies

0 followers


Minerva Biotechnologies develops cancer immunotherapies and cancer drugs to target 80% of solid tumors and to prevent cancer metastasis.

Industries

+1

Headquarters

Stage

Employees

Links

Org chart

Cynthia Bamdad

Collapse
Andrew Stewart
Head of Research And Development
Ken Reed
Director